Samsung Biologics Launches CHF 1.46B Acquisition of PolyPeptide to Scale Peptide Capabilities

The global biopharmaceutical contract manufacturing sector is undergoing a rapid transition toward complex modalities as drug developers prioritize specialized treatments for metabolic and chronic conditions. In a...

How Pharmaceutical Manufacturers Validate GMP Cleaning Protocols: ATP Bioluminescence Testing for Contamination Control

You know how quickly a single overlooked residue can turn into a recalled batch or a Form 483 citation. Good manufacturing practice cleaning validation exists precisely because...

Why Specialty Pharmacy Accreditation Matters: Standards for Pharmaceutical Distribution and Patient Outcomes

In This Article This article contains: What Is a Specialty Pharmacy and Why Does It Need Specific Standards? The Core Pillars of Pharmacy Accreditation An Overview of Leading...

Strategic Alliance Boosts Nutraceutical Innovation and Trade

The Organic & Natural Health Association has officially entered into a strategic partnership with the Shellac & Forest Products Export Promotion Council (SHEFEXIL) to bolster scientific collaboration...

Generative AI Advancing Novel Therapeutic Drug Discovery

The pharmaceutical sector is currently witnessing a profound shift in the methodology used to identify new chemical and biological entities. For decades, the discovery process relied heavily...

Machine Learning Improving Predictive Toxicology Testing

The pharmaceutical industry is currently facing a critical challenge in the management of safety risks associated with new drug candidates. For decades, the high rate of attrition...

AI Optimising Drug Development Costs and Timelines

The pharmaceutical industry is currently facing a period of intense structural adjustment as the costs associated with bringing a new therapy to market continue to rise. For...

AI Revealing Drug Targets for Neurodegenerative Disorders

The pharmaceutical industry has long struggled with the immense complexity of conditions affecting the central nervous system. For decades, the high failure rate in clinical trials for...

AI Transforming Cancer Drug Discovery and Development

The global oncology sector is currently undergoing a significant shift as the complexity of the disease continues to outpace traditional research methods. For decades, the search for...

AI Accelerating Rare Disease Drug Discovery Programs

The pharmaceutical sector is currently witnessing a fundamental shift in how orphan drugs are identified and moved through the clinical pipeline. For decades, the primary challenge for...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back